menu search

Atara biotherapeutics, inc. (atra) q3 2023 earnings call transcript

Atara biotherapeutics, Inc. (NASDAQ:ATRA ) Q3 2023 Results Conference Call November 1, 2023 9:00 AM ET ...

November 4, 2023, 11:45 am

Sensei biotherapeutics reports favorable clinical data for sns-101 at 2023 sitc annual meeting

– Clinical dose escalation data for SNS-101 monotherapy show well tolerated safety profile, potentially best-in-class pharmacokinetics, and encourag...

November 3, 2023, 8:05 pm

Sensei biotherapeutics appoints stephanie krebs, ms, mba, as chief business officer

BOSTON, Nov. 01, 2023 (GLOBE NEWSWIRE) — Sensei biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stag...

November 1, 2023, 11:30 am

Down -50.77% in 4 weeks, here's why you should you buy the dip in arcutis biotherapeutics, inc. (arqt)

Arcutis biotherapeutics, Inc. (ARQT) has become technically an oversold stock now, which implies exhaus...

November 1, 2023, 11:21 am

Zymeworks announces participation in upcoming investor conferences

VANCOUVER, British Columbia, Nov. 01, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...

November 1, 2023, 8:30 am

Arcutis biotherapeutics, inc. (arqt) loses -51.27% in 4 weeks, here's why a trend reversal may be around the corner

The heavy selling pressure might have exhausted for Arcutis biotherapeutics, Inc. (ARQT) as it is techn...

October 31, 2023, 11:21 am

Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting

SAN CARLOS, Calif., Oct. 31, 2023 (GLOBE NEWSWIRE) -- Iovance biotherapeutics, Inc. (NASDAQ: IOVA), a b...

October 31, 2023, 9:05 am

Sensei biotherapeutics to present initial clinical data from dose escalation trial of sns-101 at 2023 sitc annual meeting

BOSTON, Oct. 25, 2023 (GLOBE NEWSWIRE) -- Sensei biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage...

October 25, 2023, 9:05 am

Why is sonnet biotherapeutics (sonn) stock down 33% today?

Sonnet biotherapeutics (NASDAQ: SONN ) stock is falling on Wednesday after the biotechnology company r...

October 25, 2023, 8:42 am

Iovance biotherapeutics: testing shareholders' patience

Iovance biotherapeutics is on the cusp of its first FDA approval for its TIL therapy in the treatment o...

October 22, 2023, 9:12 am

Arcutis biotherapeutics shares sink on $100m stock sale

Arcutis biotherapeutics Inc shares slid more than 18% in pre-market trading on Friday after the early c...

October 20, 2023, 9:13 am

Arcutis announces pricing of $100 million public offering

WESTLAKE VILLAGE, Calif., Oct. 19, 2023 (GLOBE NEWSWIRE) — Arcutis biotherapeutics, Inc. (Nasdaq: ARQ...

October 20, 2023, 3:45 am

Iovance biotherapeutics: good trade setup created by the fda delay gets even better

Iovance biotherapeutics: Good Trade Setup Created By The FDA Delay Gets Even Better...

October 19, 2023, 2:35 pm

Excision biotherapeutics announces presentation of interim clinical data for ebt-101 in latent hiv at upcoming european society of gene and cell therapy (esgct) 2023 annual congress

SAN FRANCISCO, Oct. 19, 2023 (GLOBE NEWSWIRE) — Excision biotherapeutics, Inc., a clinical-stage biot...

October 19, 2023, 11:50 am

Zymeworks to host third quarter 2023 results conference call

VANCOUVER, British Columbia, Oct. 17, 2023 (GLOBE NEWSWIRE) -- Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel,...

October 17, 2023, 8:30 am

Synlogic announces reverse stock split

CAMBRIDGE, Mass., Sept. 27, 2023 (GLOBE NEWSWIRE) — Synlogic, Inc. (Nasdaq: SYBX), a clinical-stage biotechnology company advancing novel, oral, non...

September 27, 2023, 4:30 pm

Iovance biotherapeutics to present clinical and pre-clinical data for tumor infiltrating lymphocyte (til) therapies at society for tumor immunotherapy of cancer's (sitc) 38th annual meeting

SAN CARLOS, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) -- Iovance biotherapeutics, Inc. (NASDAQ: IOVA), a ...

September 27, 2023, 4:01 pm

Iovance biotherapeutics: navigates regulatory delays with strategic finesse (rating upgrade)

Iovance biotherapeutics shows promise in T-cell therapies for solid tumors despite FDA delays; robust f...

September 18, 2023, 10:43 pm

Why shares of iovance biotherapeutics jumped monday

Iovance's lead therapy lifileucel still has a chance at an early approval to treat advanced melanoma. Lifileucel is also being tested to treat several...

September 18, 2023, 12:46 pm

Why iovance biotherapeutics stock rocketed 13% higher today

At first glance, the latest regulatory news is a setback. However, there were more than a few silver linings in this development....

September 15, 2023, 4:20 pm


Search within

Pages Search Results: